INTUITIVE SURGICAL INC — Director's Dealing 2025

Mar 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2025-03-11

Reporting Person: Miller Brian Edward (EVP & Chief Digital Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-11	Common Stock	M	1834	$177.9867	Acquired	14658	Direct
2025-03-11	Common Stock	S	1834	$485.9569	Disposed	12824	Direct
2025-03-11	Common Stock	S	442	$482.824	Disposed	12382	Direct
2025-03-11	Common Stock	S	6624	$484.9711	Disposed	5758	Direct
2025-03-12	Common Stock	M	1550	$177.9867	Acquired	7308	Direct
2025-03-12	Common Stock	S	1550	$512.06	Disposed	5758	Direct
2025-03-12	Common Stock	M	2450	$208.9	Acquired	8208	Direct
2025-03-12	Common Stock	S	2450	$512.06	Disposed	5758	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-11	Non-Qualified Stock Option (right to buy)	$177.9867	M	1834	Disposed	2030-02-28	Common Stock (1834)	Direct
2025-03-12	Non-Qualified Stock Option (right to buy)	$177.9867	M	1550	Disposed	2030-02-28	Common Stock (1550)	Direct
2025-03-12	Non-Qualified Stock Option (right to buy)	$208.9	M	2450	Disposed	2029-08-28	Common Stock (2450)	Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $479.78 to $489.50 as follows: 243 shares sold at $479.78 to $480.75; 200 shares sold at $480.99to $481.50; 100 shares sold at $483.59; 100 shares sold at $485.39; 791 shares sold at $487.20 to $488.09; and 400 shares sold at $488.52 to $489.50. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $480.67 to $489.28 as follows: 270 shares sold at $480.67 to $480.99; 100 shares sold at $483.59; and 72 shares sold at $489.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $478.45 to $490.19 as follows: 702 shares sold at $478.45 to $479.29; 1,330 shares sold at $480.41 to $481.13; 200 shares sold at $481.50 to $482.50; 500 shares sold at $482.76 to $483.03; 358 shares sold at $485.39 to $486.00; 2,377 shares sold at $487.20 to $488.09; 975 shares sold at $488.52 to $489.50; and 182 shares sold at $489.69 to $490.19. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

F6: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.